Medical Health, Pharmacology Category

The Impact of Pharmacotherapy of Childhood-Onset Psychiatric Disorders on the Development of Substance Use Disorders

1 CE Hour
257 members have taken this course
Enroll In This Course

About the Course

This intermediate and above level course is tailored for healthcare professionals who are seeking to enhance their expertise. Participants at the intermediate and above levels of knowledge will delve into comprehensive learning objectives designed to deepen their understanding and proficiency in this specialized field.
This course will include in-depth exploration of the relationship between pharmacotherapy and the risk of developing substance use disorders (SUDs) in adolescents and young adults with psychiatric disorders. Participants will critically analyze the impact of pharmacological treatments on substance use, misuse, and the development of SUDs in various psychiatric conditions, including attention-deficit/hyperactivity disorder (ADHD), major depressive disorder, and psychotic disorders. Emphasizing evidence-based practice, the course delves into the nuances of treatment initiation, duration, and adequacy, highlighting the importance of early intervention and prolonged treatment in reducing SUD risk.

This course is based on the reading-based online article, The Impact of Pharmacotherapy of Childhood-Onset Psychiatric Disorders on the Development of Substance Use Disorders created by Timothy E. Wilens, MD et al. in 2022.

Publication Details

Publication Date: JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY 2022

Course Material Authors

Course Material Authors authored the material only, and were not involved in creating this CE course. They are identified here for your own evaluation of the relevancy of the material this course is based on.

Timothy E. Wilens, MD
Dr. Timothy Wilens is chief of the Division of Child and Adolescent Psychiatry and is co-director of the Center for Addiction Medicine at Massachusetts General Hospital. Dr. Wilens’ research interests include the relationship among attention deficit/hyperactivity disorder (ADHD), bipolar disorder, and substance use disorders; embedded health care models, and the pharmacotherapy of ADHD across the lifespan. He has published more than 300 peer-reviewed articles, concerning these and related topics. He has also coedited more than 80 book chapters, 4 books, and 300 abstracts and presentations for national and international scientific meetings.
Diana W. Woodward, PhD Student
Diana is a PhD student at the University of Southern California. She has more than 4 years of experience as a research assistant and has had multiple works published in peer reviewed journals.

Course Creator

Kathryn Held, Psy.D., CADC III

Kathryn Held, Psy. D associate and CADC III, is an individual therapist at Visions adolescent treatment centers. With a decade of experience in the mental health field, Kathryn specializes in the treatment of anxiety disorders, OCD, and the OCD spectrum. Kathryn also has expertise in working with LGBTQ+ adolescents while navigating complex family systems. Her current research projects include adolescent suicide and the use of OCD art interventions in anxiety and OCD treatment. She is trained in CBT, ACT and Exposure and Response Prevention. Her empathetic and artistic approach helps support, educate, and instill agency in her clients. Prior to joining the Visions team, Kathryn worked in various treatment settings including detox, sober living, and as the Program Director of a dual diagnosis outpatient treatment center.

Target Audience

Counselors, marriage and family therapists,nurses, nurse practitioners, physicians, psychologists and social workers. This course is appropriate for intermediate and above levels of knowledge.

Learning Objectives

After taking this course, you should be able to:

  1. 1 Analyze the findings on pharmacological treatments of psychiatric disorders in adolescents and young adults, specifically focusing on their impact on substance use, and the development of substance use disorders (SUDs).
  2. 2 Describe the implications of earlier-onset and longer-duration pharmacotherapy in reducing the risk of developing SUDs in youth with psychiatric disorders, considering the nuances of treatment initiation, duration, and adequacy.
  3. 3 Summarize current research findings to inform clinical decision-making processes for counselors, marriage and family therapists, psychologists, and social workers working with youth populations, regarding the integration of pharmacotherapy into comprehensive treatment plans aimed at addressing both psychiatric symptoms and mitigating the risk of SUD development.

Disclosure to Learners

CE Learning Systems adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CE activity – including faculty, planners, reviewers, or others ― are required to disclose all relevant financial relationships with ineligible entities (formerly known as commercial interests).

The following relevant financial relationships have been disclosed by this activity's planners, faculty, and the reviewer:

Planners and Reviewers

The planners of this activity have reported that they have no relevant financial relationships.

Material Authors

Any relevant financial disclosures for course material authors can be found in the article.

Course Creator

Kathryn Held, Psy.D., CADC III – No Disclosures to report

Commercial support

There is no commercial support for this distance-learning course.

$9
Enroll In This Course

Course Details

1 CE Hour
Reading Online
Course 103499

Related Topics

Adolescents Co-Occurring Disorders Depression Prescription Drugs Pharmacotherapy Distinct Populations Attention Deficit Disorder with Hyperactivity (ADHD)

Availability

This course is available until Dec 30th, 2038.

Frequently Asked Questions

Frequently Asked Questions

Yes, most likely. Look Up Your State Board for more detailed information. Logged-in site members will see the relevant approval information displayed in the Approvals tab for every course.

If you are having trouble using Impact CE, please contact us! We would be happy to accommodate your needs right away, and your input will help us make Impact CE more accessible for future users too.

Use the Enroll In This Course button and just follow the instructions! You don't pay anything until you're ready to take an exam.

To complete the course, review the course objectives, then review the material, and then pass the exam with a score of 75% or greater and lastly complete an evaluation.

Most of our self-paced courses are based on online articles available for free to the public. Some courses, such as those based on books, require that you purchase the material. Use the Materials tab for more info. Live courses simply require that you attend.

Your certificate(s) will be available to download or email immediately when you pass the course exam and complete the evaluation.

Yes! Use the Help widget at the bottom-right of the screen anywhere on Impact CE to search our help docs, or to ask our support team for help. Unlike most of our competitors, Impact CE has live US-based support reps to help you by email, chat, or phone.

Start your CE Journey now - complete your first course today, on us.

Try for free - no commitment required.

Start a Free Trial Course

Continuing Education

Confirm Action